Online inquiry

IVTScrip™ mRNA-Human AP1B1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21573MR)

This product GTTS-WK21573MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AP1B1 protein. This product can be used in Microglial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001127.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 162
UniProt ID Q10567
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AP1B1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21573MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK20693MR IVTScrip™ mRNA-Human AP5B1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AP5B1
GTTS-WK23987MR IVTScrip™ mRNA-Human ATP1B3, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ATP1B3
GTTS-WK16793MR IVTScrip™ mRNA-Human AP5B1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AP5B1
GTTS-WK24880MR IVTScrip™ mRNA-Human ATP13A3, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ATP13A3
GTTS-WK12351MR IVTScrip™ mRNA-Human ABCC9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABCC9
GTTS-WK24926MR IVTScrip™ mRNA-Human APOBR, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA APOBR
GTTS-WK19497MR IVTScrip™ mRNA-Human APBA3, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA APBA3
GTTS-WK17974MR IVTScrip™ mRNA-Human AP1G1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AP1G1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →